Who we are
Bottneuro is a commercial‑stage spin‑off from the Department of Biomedical Engineering at the University of Basel. We develop and market Miamind®, an innovative neurostimulator that delivers personalized, non‑invasive, home‑based transcranial electrical stimulation (tES) to improve the lives of people with cognitive disorders.
Operational Team
Thomas Hefti, PhD
CEO
Inspiration comes of working every day - but only with a positive mindset. I want to ensure that technology simplifies the everyday life of all those who are particularly challenged by health issues.
Bekim Osmani, PhD
Chairman & Group CEO
I am convinced that by expanding our knowledge about neurodegenerative diseases we are able to limit and counteract harmful disease progression.
Alois C. Hopf, PhD
CSO
At Bottneuro, I have taken on the challenge of digital therapy for neurodegenerative diseases, helping to expand the technology and push it towards personalised treatment.
Mahyar Joodaki
Head of Digital Therapeutics
I am fascinated about psychology and neuroscience to better understand human behavior.
Annina Ruffner
Client Service Manager
I'm a mechanical engineer at heart.
Mathias Recalde Koller
Design Engineer
David Eiler
Regulatory and QMS
Advisors
Prof. Dr. Emiliano Santarnecchi
Scientific Advisor
Prof. Dr. Raphael Guzman
Co-Founder and Clinical Advisor
Prof. Dr. phil. Andreas Monsch
Clinical Advisor
Prof. Dr. Christoph Michel
Scientific Advisor
Lucie Bréchet
Scientific Advisor
Erwan Rivet
Advisor US Market
Sophie Lamparter
Advisor US Market
Patrick Griss
Advisor to the Board
Board
Bekim Osmani
Chairman
Rolf Wildermuth
Board Member
Pascal Brenneisen
Board Member
Dr. Antonella Santuccione Chadha
Board Member
Tino Töpper
Board Member
Our Partners
